TERBUTALINE SULFATE
Generic: TERBUTALINE SULFATE
Hikma Pharmaceuticals USA Inc.Manufacturer
SUBCUTANEOUSRoute
TERBUTALINE SULFATEActive Substance
2009-05-20Original Approval
TERBUTALINE SULFATE is FDA application ANDA078630, sponsored by HIKMA FARMACEUTICA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
423 reports
2
ASTHMA
378 reports
3
WHEEZING
256 reports
4
PNEUMONIA
206 reports
5
COUGH
204 reports
6
DRUG INEFFECTIVE
151 reports
7
FATIGUE
148 reports
8
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES
140 reports
9
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
124 reports
10
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION
118 reports